News
ReNeuron's latest press releases
ReNeuron announces further pre-clinical data with its ReN003 programme for diseases of the retina . 23/04/08
Guildford, UK, 23 April 2008: ReNeuron Group plc (LSE:RENE.L) today announces further pre-clinical data regarding its ReN003 stem cell therapy programme ...
Read articleRegulatory update . 19/03/08
Guildford, UK, 19 March 2008: ReNeuron Group plc (LSE: RENE.L) today provides a further update on progress with its regulatory strategy for its ...
Regulatory update. 01/02/08
Guildford, UK, 1 February 2008:ReNeuron Group plc (LSE: RENE.L) today provides an update on progress with its Investigational New Drug (IND) application ...
Director share purchases. 08/01/08
Guildford, UK, 7 January 2008: ReNeuron Group plc (LSE: RENE.L) was advised today of the following purchases of Ordinary shares in the Company by ...
Regulatory update. 04/01/08
Guildford, UK, 3 January 2008: ReNeuron Group plc (LSE: RENE.L) today provides an update on progress with its Investigational New Drug (IND) application ...
ReNeuron to present on diabetes therapy at UK biotechnology conference . 12/12/07
Guildford, UK, 11 December 2007: ReNeuron Group plc (LSE: RENE.L) today announces that it will be participating in the London Biotechnology Network's ...
Interim Results for the six months ended 30 September 2007. 03/12/07
Summary of interim results: Successful completion of further pre-clinical studies in support of IND application to commence ...
Notification of 2007 Interim Results. 28/11/07
Guildford, UK, 28 November 2007: ReNeuron Group plc (LSE: RENE.L) today announces that it will report its interim results for the six months ended ...
1 2 3 4 5 6 7 8 >>If you would like to be alerted when a new press release is added, please click here to register with our Alerting Service.
Top of page